Antiretroviral Medicines in Low- and Middle-income Countries: Forecasts of Global and Regional Demand for 2021–2025

By the end of 2020, over 25 million people were receiving antiretroviral therapy (ART) in low- and middle-income countries. This report aims to provide countries and suppliers with estimates of the global market for antiretroviral (ARV) medicines in low- and middle-income countries for 2021–2025. The report includes estimates of the global demand for active pharmaceutical ingredients (APIs) and ARV formulations for adults receiving first-line treatment to enable suppliers to plan adjustments to their manufacturing capacity and processes.